Fang Ni

2023

In 2023, Fang Ni earned a total compensation of $1.5M as Chief Business Officer and Interim Chief Financial Officer at Black Diamond Therapeutics, a 64% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$189,361
Option Awards$823,542
Salary$450,865
Other$25,758
Total$1,489,526

Ni received $823.5K in option awards, accounting for 55% of the total pay in 2023.

Ni also received $189.4K in non-equity incentive plan, $450.9K in salary and $25.8K in other compensation.

Rankings

In 2023, Fang Ni's compensation ranked 779th out of 2,821 executives tracked by ExecPay. In other words, Ni earned more than 72.4% of executives.

ClassificationRankingPercentile
All
779
out of 2,821
72nd
Division
Manufacturing
463
out of 1,551
70th
Major group
Chemicals And Allied Products
318
out of 877
64th
Industry group
Drugs
310
out of 840
63rd
Industry
Biological Products, Except Diagnostic Substances
98
out of 204
52nd
Source: SEC filing on April 24, 2024.

Ni's colleagues

We found three more compensation records of executives who worked with Fang Ni at Black Diamond Therapeutics in 2023.

2023

Mark Velleca

Black Diamond Therapeutics

Chief Executive Officer

2023

David Epstein

Black Diamond Therapeutics

Chief Executive Officer

2023

Sergey Yurasov

Black Diamond Therapeutics

Chief Medical Officer

News

In-depth

You may also like